Anavex Life Sciences Corp (AVXL)

[Investor2014]

MacFarlane's interpretation of the MMSE and ADCS-ADL graphs.

“The MMSE declined 45% less and the ADCS-ADL declined 56% less than what we would have expected from the historical control data,” Dr. Macfarlane said. “This is not only statistically significant, but clearly clinically meaningful for patients.”

http://www.mdedge.com/clinicalneurologynews/article/120066/alzheimers-cognition/sigma-1-agonist-presses-forward-after